Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1977 1
1979 1
1981 1
1982 7
1991 1
1993 2
1994 2
1996 2
1999 2
2000 3
2001 1
2002 1
2003 4
2004 4
2005 1
2006 5
2007 8
2008 10
2009 27
2010 13
2011 11
2012 3
2013 1
2015 4
2016 4
2017 9
2018 18
2019 13
2020 4
2021 16
2022 12
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma.
Yamada S, Miyata H, Isono M, Hori K, Yanagawa J, Murai A, Minowa T, Mizue Y, Sasaki K, Murata K, Tokita S, Nakatsugawa M, Iwabuchi S, Hashimoto S, Kubo T, Kanaseki T, Tsukahara T, Abe T, Shinohara N, Hirohashi Y, Torigoe T. Yamada S, et al. Among authors: tokita s. Cancer Immunol Immunother. 2023 Jul;72(7):2057-2065. doi: 10.1007/s00262-023-03388-5. Epub 2023 Feb 16. Cancer Immunol Immunother. 2023. PMID: 36795123
12  mJ Yb:YAG/Cr:YAG microchip laser.
Guo X, Tokita S, Kawanaka J. Guo X, et al. Among authors: tokita s. Opt Lett. 2018 Feb 1;43(3):459-461. doi: 10.1364/OL.43.000459. Opt Lett. 2018. PMID: 29400814
Treatment patterns and satisfaction in patients with type 2 diabetes newly initiating oral monotherapy with antidiabetic drugs in Japan: results from the prospective Real-world Observational Study on Patient Outcomes in Diabetes (RESPOND).
Tajima A, Tobe K, Eiki JI, Origasa H, Watada H, Shimomura I, Tokita S, Kadowaki T. Tajima A, et al. Among authors: tokita s. BMJ Open Diabetes Res Care. 2022 Dec;10(6):e003032. doi: 10.1136/bmjdrc-2022-003032. BMJ Open Diabetes Res Care. 2022. PMID: 36585033 Free PMC article.
GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.
Miyata H, Hirohashi Y, Yamada S, Yanagawa J, Murai A, Hashimoto S, Tokita S, Hori K, Abe T, Kubo T, Tsukahara T, Kanaseki T, Shinohara N, Torigoe T. Miyata H, et al. Among authors: tokita s. Cancer Immunol Immunother. 2022 Apr;71(4):795-806. doi: 10.1007/s00262-021-03025-z. Epub 2021 Aug 18. Cancer Immunol Immunother. 2022. PMID: 34405274
Boosting laser-ion acceleration with multi-picosecond pulses.
Yogo A, Mima K, Iwata N, Tosaki S, Morace A, Arikawa Y, Fujioka S, Johzaki T, Sentoku Y, Nishimura H, Sagisaka A, Matsuo K, Kamitsukasa N, Kojima S, Nagatomo H, Nakai M, Shiraga H, Murakami M, Tokita S, Kawanaka J, Miyanaga N, Yamanoi K, Norimatsu T, Sakagami H, Bulanov SV, Kondo K, Azechi H. Yogo A, et al. Among authors: tokita s. Sci Rep. 2017 Feb 13;7:42451. doi: 10.1038/srep42451. Sci Rep. 2017. PMID: 28211913 Free PMC article.
Elevation of anti-elastin antibody in patients with asthma.
Tokita S, Sugiyama K, Wakayama T, Arifuku H, Otsuji N, Sugitate K, Owada T, Koyama K, Hirata H, Arima M, Ueda Y, Fukushima Y. Tokita S, et al. Asian Pac J Allergy Immunol. 2021 Jul 11. doi: 10.12932/AP-010221-1052. Online ahead of print. Asian Pac J Allergy Immunol. 2021. PMID: 34246206 Free article.
183 results